Concepedia

Maciej Jabłkowski

MJ

17

Publications

1.1K

Citations

13

H-Index

2009

Active since

Affiliations

Medical University of Lodz(Current)

Gilead Sciences (United States)

Medical University of Białystok

Chinese University of Hong Kong

University of Toronto

Maciej Jabłkowski is an author at Medical University of Lodz specializing in medicine, hepatology, and viral hepatitis.

ORCID

Top concepts

Publications per year

2009–2024

17

Publications

17

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

, , +9

The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naïve hepatitis C patients #

Robert Flisiak, S.V. Feinman, Maciej Jabłkowski et al. · Hepatology · 2009 · 221 citations · Full text

Real‐world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study

Robert Flisiak, Ewa Janczewska, Marta Wawrzynowicz‐Syczewska et al. · Alimentary Pharmacology & Therapeutics · 2016 · 99 citations · Full text

Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised study

Scott Fung, Peter Kwan, Milotka Fabri et al. · Journal of Hepatology · 2016 · 60 citations · Full text

Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety

Henry Lik‐Yuen Chan, Young‐Suk Lim, Kosh Agarwal et al. · The American Journal of Gastroenterology · 2023 · 55 citations · Full text

Rows per page

1–5 of 17